Prevalence and Mechanisms of Erythromycin Resistance in Group A and Group B Streptococcus: Implications for Reporting Susceptibility Results

作者: M. Desjardins , K. L. Delgaty , K. Ramotar , C. Seetaram , B. Toye

DOI: 10.1128/JCM.42.12.5620-5623.2004

关键词:

摘要: Increased rates of erythromycin resistance among group B Streptococcus (GBS) and A (GAS) have been reported. Cross-resistance to clindamycin may be present, depending on the mechanism resistance. We determined prevalence macrolide-resistant determinants in GBS GAS isolates guide laboratory reporting susceptibility. Susceptibilities were by disk diffusion broth microdilution methods. Inducible constitutive was double-disk method. The presence ermTR, ermB, mefA genes confirmed PCR. Of 338 isolates, 55 (17%) resistant erythromycin, whereas 26 (8%) clindamycin. erm methylase gene identified 48 22 which had inducible remaining seven mefA. 593 49 6 (1%) clindamycin, respectively. Erythromycin due 33 14 erm-mediated (9 5 resistance). In our population, predominantly mediated erm. Regional differences mechanisms need taken into consideration when deciding whether report susceptibility results basis vitro test results. Testing method would an approach that could used address this issue, especially for GAS.

参考文章(25)
Bülent Bozdogan, Latifa Berrezouga, Ming-Shang Kuo, David A. Yurek, Kathleen A. Farley, Brian J. Stockman, Roland Leclercq, A New Resistance Gene, linB, Conferring Resistance to Lincosamides by Nucleotidylation in Enterococcus faecium HM1025 Antimicrobial Agents and Chemotherapy. ,vol. 43, pp. 925- 929 ,(1999) , 10.1128/AAC.43.4.925
Chatrchai Watanakunakorn, Clindamycin therapy of staphylococcus aureus endocarditis The American Journal of Medicine. ,vol. 60, pp. 419- 425 ,(1976) , 10.1016/0002-9343(76)90758-0
Erika Bruck, National Committee for Clinical Laboratory Standards. Pediatrics. ,vol. 65, pp. 187- 188 ,(1980)
Howard Faden, Shawn Ferguson, None, Community-acquired methicillin-resistant Staphylococcus aureus and intrafamily spread of pustular disease. Pediatric Infectious Disease Journal. ,vol. 20, pp. 554- 555 ,(2001) , 10.1097/00006454-200105000-00023
G. K. Siberry, T. Tekle, K. Carroll, J. Dick, Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clinical Infectious Diseases. ,vol. 37, pp. 1257- 1260 ,(2003) , 10.1086/377501
David R. Murdoch, L. Barth Reller, Antimicrobial Susceptibilities of Group B Streptococci Isolated from Patients with Invasive Disease: 10-Year Perspective Antimicrobial Agents and Chemotherapy. ,vol. 45, pp. 3623- 3624 ,(2001) , 10.1128/AAC.45.12.3623-3624.2001
C. Betriu, E. Culebras, M. Gómez, I. Rodríguez-Avial, B. A. Sánchez, M. C. Ágreda, J. J. Picazo, Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrobial Agents and Chemotherapy. ,vol. 47, pp. 1112- 1114 ,(2003) , 10.1128/AAC.47.3.1112-1114.2003
Kevin C. Katz, Allison J. McGeer, Carla L. Duncan, Aisha Ashi-Sulaiman, Barbara M. Willey, Alicia Sarabia, Jacquie McCann, Sylvia Pong-Porter, Yana Rzayev, Joyce S. de Azavedo, Donald E. Low, Emergence of Macrolide Resistance in Throat Culture Isolates of Group A Streptococci in Ontario, Canada, in 2001 Antimicrobial Agents and Chemotherapy. ,vol. 47, pp. 2370- 2372 ,(2003) , 10.1128/AAC.47.7.2370-2372.2003